Tilray | TRLY - Trade Creditors

Stock Price
9.29
Daily Change
0.30 3.34%
Monthly
-6.82%
Yearly
1,138.67%
Q2 Forecast
8.92

Tilray reported $114.5M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Acasti Pharma USD 459K 881K Sep/2025
Akebia Therapeutics USD 21.18M 11.1M Dec/2025
Alaunos Therapeutics USD 843K 34K Sep/2025
Aurora Cannabis CAD 68.03M 18.68M Dec/2025
Avita Medical AUD 8.96M 1.69M Dec/2025
Canopy Growth CAD 19.96M 1.83M Dec/2025
Cronos Group USD 11.64M 775K Dec/2025
Dianthus Therapeutics USD 9.72M 3.02M Dec/2025
Divis Laboratories Ltd INR 10.4B 1.3B Sep/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
IQVIA Holdings USD 3.75B 201M Dec/2025
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Moderna USD 317M 50M Dec/2025
Organigram Holdings CAD 71.08M 18.17M Dec/2025
Organon & Co USD 1.07B 7M Sep/2025
Revvity USD 185.46M 9.66M Dec/2025
Tectonic Therapeutic USD 1.09M 392K Dec/2025
Tilray USD 114.5M 3.69M Sep/2025
Viatris USD 1.33B 6.4M Sep/2025
Xeris Pharmaceuticals USD 3.08M 3.45M Dec/2025
Zealand Pharma A/S 346.6M 102.71M Dec/2025